STOK — Stoke Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Stoke Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	220	230	201	217	285
Net Total Accounts Receivable
Net Total Receivables	0.132	0.588	0.064	0.7	7.91
Prepaid Expenses
Total Other Current Assets
Total Current Assets	229	244	215	233	306
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.08	11.4	12.4	8.25	6.25
Long Term Investments
Other Long Term Assets
Total Assets	239	256	228	272	418
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.1	31.4	30.8	40.1	57.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.1	71.2	68.8	42.5	66
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	218	185	160	229	352
Total Liabilities & Shareholders' Equity	239	256	228	272	418
Total Common Shares Outstanding